Emulex hoax

The Emulex hoax was an instance of securities fraud perpetrated by 23-year-old Mark Jakob on August 24, 2000. Jakob realized a profit of more than $240,000 by shorting the stock but was arrested within a week by the FBI and sentenced to 44 months in prison. Provided by Wikipedia
Showing 1 - 5 results of 5 for search 'Mark Jakob', query time: 0.03s Refine Results
  1. 1
    Neurotoxin injection in benign submandibular gland hypertrophy: A first choice treatment

    Neurotoxin injection in benign submandibular gland hypertrophy: A first choice treatment by Chrisanthi Karapantzou, Mark Jakob, Martin Canis

    Published 2020-04-01
    Get full text
    Article
  2. 2
    Pluripotent Stem Cell-Derived Mesenchymal Stem Cells Show Comparable Functionality to Their Autologous Origin

    Pluripotent Stem Cell-Derived Mesenchymal Stem Cells Show Comparable Functionality to Their Autologous Origin by Mark Jakob, Mario Hambrecht, Jennifer L. Spiegel, Julia Kitz, Martin Canis, Ralf Dressel, Katrin Streckfuss-Bömeke

    Published 2020-12-01
    Get full text
    Article
  3. 3
    Mesenchymal stem cells augment the anti-bacterial activity of neutrophil granulocytes.

    Mesenchymal stem cells augment the anti-bacterial activity of neutrophil granulocytes. by Sven Brandau, Mark Jakob, Kirsten Bruderek, Friedrich Bootz, Bernd Giebel, Stefan Radtke, Katharina Mauel, Marcus Jäger, Stefanie B Flohé, Stephan Lang

    Published 2014-01-01
    Get full text
    Article
  4. 4
    A High-Throughput Method as a Diagnostic Tool for HIV Detection in Patient-Specific Induced Pluripotent Stem Cells Generated by Different Reprogramming Methods

    A High-Throughput Method as a Diagnostic Tool for HIV Detection in Patient-Specific Induced Pluripotent Stem Cells Generated by Different Reprogramming Methods by Daniela Hübscher, Sabine Rebs, Luis Haupt, Thomas Borchert, Celina Isabell Guessoum, Franziska Treu, Steffen Köhne, Andreas Maus, Mario Hambrecht, Samuel Sossalla, Ralf Dressel, Angela Uy, Mark Jakob, Gerd Hasenfuss, Katrin Streckfuss-Bömeke

    Published 2019-01-01
    Get full text
    Article
  5. 5
    EpCAM ectodomain EpEX is a ligand of EGFR that counteracts EGF-mediated epithelial-mesenchymal transition through modulation of phospho-ERK1/2 in head and neck cancers.

    EpCAM ectodomain EpEX is a ligand of EGFR that counteracts EGF-mediated epithelial-mesenchymal transition through modulation of phospho-ERK1/2 in head and neck cancers. by Min Pan, Henrik Schinke, Elke Luxenburger, Gisela Kranz, Julius Shakhtour, Darko Libl, Yuanchi Huang, Aljaž Gaber, Miha Pavšič, Brigita Lenarčič, Julia Kitz, Mark Jakob, Sabina Schwenk-Zieger, Martin Canis, Julia Hess, Kristian Unger, Philipp Baumeister, Olivier Gires

    Published 2018-09-01
    Get full text
    Article

Search Tools: